Capricor Therapeutics Inc
Change company Symbol lookup
Select an option...
CAPR Capricor Therapeutics Inc
PFE Pfizer Inc
SCBH Seacoast Commerce Banc Holdings
PHX Panhandle Oil and Gas Inc
BTU Peabody Energy Corp
CLNY Colony Capital Inc
BAC Bank of America Corp
USAK USA Truck Inc
BABA Alibaba Group Holding Ltd
CTL Centurylink Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing regenerative medicine and large molecule products for the treatment of disease, with a primary focus on the treatment of cardiovascular diseases, including orphan indications. Its product candidate, CAP-1002, a cardiosphere-derived cell product, is being tested in the ALLSTAR Phase II clinical study on patients having suffered a myocardial infarction (MI), while the DYNAMIC clinical study is testing CAP-1002 in patients in the advanced-stage of heart failure. CAP-1002 is also being tested in the HOPE-Duchenne Phase I/II clinical study for use in connection with Duchenne muscular dystrophy-related cardiomyopathy. Cenderitide, a dual receptor natriuretic peptide agonist, is being tested in a Phase II clinical study. Exosomes are nano-sized, membrane-enclosed vesicles.

Closing Price
$1.82
Day's Change
-0.01 (-0.55%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.97
Day's Low
1.79
Volume
(Light)
Volume:
175,272

10-day average volume:
303,479
175,272
  • Prev Close
    1.83
  • Today's Open
    1.87
  • Day's Range
    1.79-1.97
  • Avg Vol (10-day)
    303.5K
  • Last (time)
    4:00p ET 01/21/20
  • Last (size)
    3
  • 52-Wk Range
    1.00 - 8.85
    LowHigh
  • (07/15/19 - 12/16/19)
    82.00%
  • 117.2%
  • Market Cap
    8.7M
  • Shares Outstanding
    4.8M
  • -2.84
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.2
  • 5.17
  • (% of float 12/31/19)
    0.38

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.